ID   ACSL5_RAT               Reviewed;         683 AA.
AC   O88813;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   24-JAN-2024, entry version 139.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 5 {ECO:0000305};
DE            EC=6.2.1.3 {ECO:0000269|PubMed:28209804};
DE   AltName: Full=Arachidonate--CoA ligase {ECO:0000305};
DE            EC=6.2.1.15 {ECO:0000269|PubMed:28209804};
DE   AltName: Full=Long-chain acyl-CoA synthetase 5;
DE            Short=LACS 5;
GN   Name=Acsl5 {ECO:0000312|RGD:69402}; Synonyms=Acs5, Facl5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=9722683; DOI=10.1093/oxfordjournals.jbchem.a022165;
RA   Oikawa E., Iijima H., Suzuki T., Sasano H., Sato H., Kamataki A.,
RA   Nagura H., Kang M.-J., Fujino T., Suzuki H., Yamamoto T.T.;
RT   "A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial
RT   cells and proliferating preadipocytes.";
RL   J. Biochem. 124:679-685(1998).
RN   [2]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Brain;
RX   PubMed=15683247; DOI=10.1021/bi047721l;
RA   Van Horn C.G., Caviglia J.M., Li L.O., Wang S., Granger D.A., Coleman R.A.;
RT   "Characterization of recombinant long-chain rat acyl-CoA synthetase
RT   isoforms 3 and 6: identification of a novel variant of isoform 6.";
RL   Biochemistry 44:1635-1642(2005).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=16263710; DOI=10.1074/jbc.m507646200;
RA   Mashek D.G., McKenzie M.A., Van Horn C.G., Coleman R.A.;
RT   "Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and
RT   partitioning to cellular triacylglycerol in McArdle-RH7777 cells.";
RL   J. Biol. Chem. 281:945-950(2006).
RN   [4]
RP   FUNCTION.
RX   PubMed=17761945; DOI=10.1161/atvbaha.107.148429;
RA   Zhou Y., Abidi P., Kim A., Chen W., Huang T.-T., Kraemer F.B., Liu J.;
RT   "Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m
RT   reduces hypertriglyceridemia through enhanced beta-oxidation.";
RL   Arterioscler. Thromb. Vasc. Biol. 27:2198-2205(2007).
RN   [5]
RP   CATALYTIC ACTIVITY, FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=28209804; DOI=10.1194/jlr.m072512;
RA   Klett E.L., Chen S., Yechoor A., Lih F.B., Coleman R.A.;
RT   "Long-chain acyl-CoA synthetase isoforms differ in preferences for
RT   eicosanoid species and long-chain fatty acids.";
RL   J. Lipid Res. 58:884-894(2017).
RN   [6]
RP   ERRATUM OF PUBMED:28209804.
RX   PubMed=29196521; DOI=10.1194/jlr.m072512err;
RA   Klett E.L., Chen S., Yechoor A., Lih F.B., Coleman R.A.;
RL   J. Lipid Res. 58:2365-2365(2017).
CC   -!- FUNCTION: Catalyzes the conversion of long-chain fatty acids to their
CC       active form acyl-CoAs for both synthesis of cellular lipids, and
CC       degradation via beta-oxidation (PubMed:28209804). ACSL5 may sensitize
CC       epithelial cells to apoptosis specifically triggered by the death
CC       ligand TRAIL at the villus tip of the crypt-villus axis of the small
CC       intestine (By similarity). May have a role in the survival of glioma
CC       cells (By similarity). May activate fatty acids from exogenous sources
CC       for the synthesis of triacylglycerol destined for intracellular
CC       storage. It was suggested that it may also stimulate fatty acid
CC       oxidation. Utilizes a wide range of saturated fatty acids with a
CC       preference for C16-C18 unsaturated fatty acids. {ECO:0000250,
CC       ECO:0000269|PubMed:16263710, ECO:0000269|PubMed:17761945,
CC       ECO:0000269|PubMed:28209804, ECO:0000269|PubMed:9722683}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl-
CC         CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3;
CC         Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:456215; EC=6.2.1.15;
CC         Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + ATP + CoA = 15-
CC         hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52116, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:78832, ChEBI:CHEBI:136409,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52117;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + ATP + CoA = 12-
CC         hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52112, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:90718, ChEBI:CHEBI:136408,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52113;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = 5-
CC         hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52108, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:65341, ChEBI:CHEBI:136407,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52109;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=14,15-epoxy-(5Z,8Z,11Z)-eicosatrienoate + ATP + CoA = 14,15-
CC         epoxy-(5Z,8Z,11Z)-eicosatrienoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52016, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:84024, ChEBI:CHEBI:136117,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52017;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoate + ATP + CoA = 11,12-
CC         epoxy-(5Z,8Z,14Z)-eicosatrienoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52012, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:76625, ChEBI:CHEBI:136115,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52013;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl-
CC         CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q9ULC5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752;
CC         Evidence={ECO:0000250|UniProtKB:Q9ULC5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP
CC         + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526,
CC         ChEBI:CHEBI:72745, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000250|UniProtKB:Q9ULC5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36140;
CC         Evidence={ECO:0000250|UniProtKB:Q9ULC5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoate + ATP + CoA = (9Z)-octadecenoyl-CoA + AMP +
CC         diphosphate; Xref=Rhea:RHEA:33607, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:28209804};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33608;
CC         Evidence={ECO:0000305|PubMed:28209804};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=666 uM for ATP {ECO:0000269|PubMed:15683247};
CC         KM=2.4 uM for CoA {ECO:0000269|PubMed:15683247};
CC         KM=8.6 uM for palmitate {ECO:0000269|PubMed:15683247};
CC         KM=6.5 uM for palmitate (when expressed in bacteria)
CC         {ECO:0000269|PubMed:28209804};
CC         KM=4.4 uM for stearate (when expressed in bacteria)
CC         {ECO:0000269|PubMed:28209804};
CC         KM=6.3 uM for oleate (when expressed in bacteria)
CC         {ECO:0000269|PubMed:28209804};
CC         KM=5.8 uM for linoleate (when expressed in bacteria)
CC         {ECO:0000269|PubMed:28209804};
CC         KM=1.8 uM for arachidonate (when expressed in bacteria)
CC         {ECO:0000269|PubMed:28209804};
CC         Vmax=5053 nmol/min/mg enzyme with palmitate as substrate (when
CC         expressed in bacteria) {ECO:0000269|PubMed:28209804};
CC         Vmax=2164 nmol/min/mg enzyme with stearate as substrate (when
CC         expressed in bacteria) {ECO:0000269|PubMed:28209804};
CC         Vmax=3726 nmol/min/mg enzyme with oleate as substrate (when expressed
CC         in bacteria) {ECO:0000269|PubMed:28209804};
CC         Vmax=1351 nmol/min/mg enzyme with linoleate as substrate (when
CC         expressed in bacteria) {ECO:0000269|PubMed:28209804};
CC         Vmax=1880 nmol/min/mg enzyme with arachidonate as substrate (when
CC         expressed in bacteria) {ECO:0000269|PubMed:28209804};
CC         Vmax=130 nmol/min/mg enzyme with palmitate as substrate
CC         {ECO:0000269|PubMed:15683247};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16263710}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:16263710}. Mitochondrion
CC       outer membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-
CC       pass type III membrane protein {ECO:0000250}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9ULC5}.
CC   -!- TISSUE SPECIFICITY: Expressed most abundantly in the small intestine,
CC       and to a much lesser extent in the lung, liver, adrenal gland, adipose
CC       tissue and kidney. {ECO:0000269|PubMed:9722683}.
CC   -!- INDUCTION: Expression decreases in response to fast and increases after
CC       high sucrose diet. {ECO:0000269|PubMed:16263710}.
CC   -!- MISCELLANEOUS: 5 rat isozymes encoded by different genes have been
CC       described. ACSL6 corresponds to isozyme 2 (ACS2).
CC       {ECO:0000303|PubMed:15683247}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB012933; BAA33581.1; -; mRNA.
DR   PIR; JE0262; JE0262.
DR   RefSeq; NP_446059.1; NM_053607.1.
DR   AlphaFoldDB; O88813; -.
DR   SMR; O88813; -.
DR   IntAct; O88813; 1.
DR   STRING; 10116.ENSRNOP00000022126; -.
DR   SwissLipids; SLP:000001685; -.
DR   iPTMnet; O88813; -.
DR   PhosphoSitePlus; O88813; -.
DR   PaxDb; 10116-ENSRNOP00000022126; -.
DR   GeneID; 94340; -.
DR   KEGG; rno:94340; -.
DR   UCSC; RGD:69402; rat.
DR   AGR; RGD:69402; -.
DR   CTD; 51703; -.
DR   RGD; 69402; Acsl5.
DR   eggNOG; KOG1256; Eukaryota.
DR   InParanoid; O88813; -.
DR   OrthoDB; 443463at2759; -.
DR   PhylomeDB; O88813; -.
DR   BRENDA; 6.2.1.3; 5301.
DR   Reactome; R-RNO-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   SABIO-RK; O88813; -.
DR   PRO; PR:O88813; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0090434; F:oleoyl-CoA ligase activity; ISS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; TAS:RGD.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; IGI:RGD.
DR   GO; GO:0010747; P:positive regulation of long-chain fatty acid import across plasma membrane; IDA:RGD.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; IDA:RGD.
DR   GO; GO:0070723; P:response to cholesterol; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0009744; P:response to sucrose; IEP:RGD.
DR   CDD; cd05927; LC-FACS_euk; 1.
DR   Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig_com.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR045311; LC-FACS_euk.
DR   PANTHER; PTHR43272; LONG-CHAIN-FATTY-ACID--COA LIGASE; 1.
DR   PANTHER; PTHR43272:SF3; LONG-CHAIN-FATTY-ACID--COA LIGASE 5; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell membrane; Endoplasmic reticulum;
KW   Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..683
FT                   /note="Long-chain-fatty-acid--CoA ligase 5"
FT                   /id="PRO_0000193114"
FT   TRANSMEM        12..32
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        33..683
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         361
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZR0"
SQ   SEQUENCE   683 AA;  76405 MW;  D4EC2A58FD29040C CRC64;
     MLFIFNFLFS PLPTPALICL LTFGTAIFLW LINRPQPVLP LIDLDNQSVG IEGGARRGAF
     QKNNDLILYY FSDAKTLYEV FQRGLAVSDN GPCLGYRKPN QPYKWISYKQ VSDRAEYLGS
     CLLHKGYKPS QDQFIGIFAQ NRPEWVISEL ACYTYSMVAV PLYDTLGAEA IIYVINRADI
     SVVICDTPQK ATMLIENVEK DLTPGLKTVI LMDPFDDDLM KRGEKCGIEM LSLHDAENLG
     KENFKKPMPP NPEDLSVICF TSGTTGDPKG AMLTHQNIVS NMAAFLKFLE PIFQPTPEDV
     TISYLPLAHM FERLVQGVIF SCGGKIGFFQ GDIRLLPDDM KALKPTVFPT VPRLLNRVYD
     KVQNEAKTPL KKFLLNLAII SKFNEVRNGI IRRNSLWDKL VFSKIQSSLG GKVRLMITGA
     APISTPVLTF FRAAMGCWVF EAYGQTECTA GCSITSPGDW TAGHVGTPVS CNFVKLEDVA
     DMNYFSVNNE GEICIKGNNV FKGYLKDPEK TQEVLDKDGW LHTGDIGRWL PNGTLKIIDR
     KKNIFKLAQG EYIAPEKIEN VYSRSRPILQ VFVHGESLRS FLIGVVVPDP ESLPSFAAKI
     GVKGSFEELC QNQCVKKAIL EDLQKVGKEG GLKSFEQVKS IFVHPEPFSI ENGLLTPTLK
     AKRVELAKFF QTQIKSLYES IEE
//
